Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
McMaster University
$27,000.00
GDF15 as a Potential Therapeutic Target to Treat Anxiety in Diabetes
FY 2025-26
Summary
There is a bi-directional relationship between mental and metabolic health. Depression and anxiety increase the risk for developing progressive insulin resistance and type 2 diabetes. Crucially, anxiety and depression in type 1 diabetes occur independently of obesity, another major risk factor for mental health issues. However, mechanisms linking diabetes with anxiety are not understood.
Psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis, elevating cortisol and increasing insulin resistance; thereby promoting hyperglycemia. Dysregulation of the HPA axis is common in those with diabetes and includes elevated basal cortisol and adrenocorticotropic hormone (ACTH), impaired dexamethasone suppression and exaggerated cortisol response to CRH; all of which weaken the negative feedback and heighten sensitivity within the HPA axis, respectively.
Growth differentiation factor 15 (GDF15), a TGFB-related cytokine with both metabolic and behavioural effects, has been recently shown to activate the HPA axis raising cortisol levels. Mice over-expressing GDF15 display anxiety-like behaviours, while genetically blocking GDF15 reverses these effects.
My masters project will use the well-established model of diabetes in mice to analyze the progression of anxiety over the progression of glucose dysregulation. I will examine behavioural changes through light-dark box tests, examine neural stress responses through measuring c-Fos expression in different regions of the brain, and collect tissue to determine the source of GDF15. My project aims to clarify how metabolic dysfunction influences anxiety and stress related pathways, contributing to advancements in both metabolic and psychological outcomes for people with diabetes.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573000
Name
Payne Alice E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
GDF15 as a Potential Therapeutic Target to Treat Anxiety in Diabetes
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Anxiety; Behavioural Analysis; Beta-Adrenergic-Signaling; Brain Region Mapping; Diabetes; Energy Balance; Gdf15; Hypothalamic-Pituitary-Axis; Metabolism; Mouse Model
Abstract
There is a bi-directional relationship between mental and metabolic health. Depression and anxiety increase the risk for developing progressive insulin resistance and type 2 diabetes. Crucially, anxiety and depression in type 1 diabetes occur independently of obesity, another major risk factor for mental health issues. However, mechanisms linking diabetes with anxiety are not understood.
Psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis, elevating cortisol and increasing insulin resistance; thereby promoting hyperglycemia. Dysregulation of the HPA axis is common in those with diabetes and includes elevated basal cortisol and adrenocorticotropic hormone (ACTH), impaired dexamethasone suppression and exaggerated cortisol response to CRH; all of which weaken the negative feedback and heighten sensitivity within the HPA axis, respectively.
Growth differentiation factor 15 (GDF15), a TGFB-related cytokine with both metabolic and behavioural effects, has been recently shown to activate the HPA axis raising cortisol levels. Mice over-expressing GDF15 display anxiety-like behaviours, while genetically blocking GDF15 reverses these effects.
My masters project will use the well-established model of diabetes in mice to analyze the progression of anxiety over the progression of glucose dysregulation. I will examine behavioural changes through light-dark box tests, examine neural stress responses through measuring c-Fos expression in different regions of the brain, and collect tissue to determine the source of GDF15. My project aims to clarify how metabolic dysfunction influences anxiety and stress related pathways, contributing to advancements in both metabolic and psychological outcomes for people with diabetes.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Payne, Alice E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~